Cargando…
An Immune-Related Gene Prognostic Index for Triple-Negative Breast Cancer Integrates Multiple Aspects of Tumor-Immune Microenvironment
SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is the most refractory subtype of breast cancer. Immune checkpoint inhibitor (ICI) therapy has made progress in TNBC treatment. PD-L1 expression is a useful biomarker of ICI therapy efficacy. However, tumor-immune microenvironment (TIME) factors,...
Autores principales: | Wang, Xiaowei, Su, Wenjia, Tang, Dabei, Jing, Jing, Xiong, Jing, Deng, Yuwei, Liu, Huili, Ma, Wenjie, Liu, Zhaoliang, Zhang, Qingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582543/ https://www.ncbi.nlm.nih.gov/pubmed/34771505 http://dx.doi.org/10.3390/cancers13215342 |
Ejemplares similares
-
Prognostic significance of systemic immune-inflammation index in triple-negative breast cancer
por: Liu, Jingxin, et al.
Publicado: (2019) -
Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
por: Liu, Ji, et al.
Publicado: (2022) -
Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis
por: Dong, Tieying, et al.
Publicado: (2017) -
Construction of a prognostic model for triple‐negative breast cancer based on immune‐related genes, and associations between the tumor immune microenvironment and immunological therapy
por: Zhu, Yue, et al.
Publicado: (2023) -
Cross-Platform in-silico Analyses Exploring Tumor Immune Microenvironment with Prognostic Value in Triple-Negative Breast Cancer
por: Kok, Victor C, et al.
Publicado: (2022)